Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,034 | -7,996 | -5,340 | -8,979 | -7,343 |
| Depreciation Amortization | 157 | 105 | 52 | 189 | 139 |
| Accounts receivable | 175 | 173 | 163 | -169 | -146 |
| Accounts payable and accrued liabilities | 357 | 127 | 116 | 294 | 212 |
| Other Working Capital | 414 | 58 | -31 | 29 | -60 |
| Other Operating Activity | 1,557 | 2,061 | 2,261 | 407 | 1,316 |
| Operating Cash Flow | $-8,374 | $-5,473 | $-2,779 | $-8,230 | $-5,883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,533 | 4,536 | 2,403 | 621 | -924 |
| PPE Investments | -36 | -36 | -36 | -106 | -94 |
| Investing Cash Flow | $6,497 | $4,499 | $2,367 | $515 | $-1,018 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,054 | 2,011 | 1,084 | 7,528 | 7,528 |
| Other Financing Activity | -122 | -30 | 9 | -149 | -22 |
| Financing Cash Flow | $1,932 | $1,981 | $1,093 | $7,379 | $7,506 |
| Beginning Cash Position | 548 | 548 | 548 | 884 | 884 |
| End Cash Position | 602 | 1,555 | 1,229 | 548 | 1,489 |
| Net Cash Flow | $55 | $1,007 | $681 | $-337 | $605 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,374 | -5,473 | -2,779 | -8,230 | -5,883 |
| Capital Expenditure | -36 | -36 | -36 | -106 | -94 |
| Free Cash Flow | -8,410 | -5,509 | -2,815 | -8,337 | -5,976 |